Synovus price target raised to $37 from $34 at RBC Capital

RBC Capital raised the firm’s price target on Synovus to $37 from $34 and keeps an Outperform rating on the shares. The company’s guidance updates were “favorable”, showing fundamentals in Q4 to date trending better than prior expectations, while its newly introduced 2024 guidance is suggesting continued momentum into next year, the analyst tells investors in a research note.